ARCHIVES

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Ethics Commission Remains Split On Compensation But Tells To Develop Pilot Program Proposal

May 15, 1981

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

NCI, NSF fund awards in nanotech training.

September 23, 2005